Varma Mutual Pension Insurance Co Takes Position in HCA Healthcare, Inc. $HCA

Varma Mutual Pension Insurance Co bought a new stake in HCA Healthcare, Inc. (NYSE:HCAFree Report) during the second quarter, Holdings Channel reports. The firm bought 17,563 shares of the company’s stock, valued at approximately $6,848,000.

Other institutional investors have also made changes to their positions in the company. Sumitomo Life Insurance Co. lifted its position in shares of HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after purchasing an additional 20 shares during the last quarter. MJP Associates Inc. ADV lifted its holdings in shares of HCA Healthcare by 2.9% during the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock worth $350,000 after buying an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC increased its position in HCA Healthcare by 7.5% during the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after acquiring an additional 21 shares during the period. Anchyra Partners LLC grew its position in HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after purchasing an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd raised its position in shares of HCA Healthcare by 0.6% during the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after buying an additional 22 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Trading Down 0.0%

NYSE HCA opened at $429.08 on Monday. The firm has a market cap of $92.90 billion, a price-to-earnings ratio of 14.36, a PEG ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a 1-year low of $353.99 and a 1-year high of $556.52. The company has a 50 day moving average of $397.16 and a 200-day moving average of $443.77.

HCA Healthcare (NYSE:HCAGet Free Report) last released its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period in the prior year, the company earned $6.84 EPS. On average, analysts forecast that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is 10.45%.

Analyst Ratings Changes

Several equities analysts recently issued reports on HCA shares. Wall Street Zen lowered HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Raymond James Financial set a $528.00 price objective on HCA Healthcare in a research report on Tuesday, July 7th. KeyCorp decreased their price target on shares of HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating on the stock in a research note on Monday, July 27th. Leerink Partners reduced their price objective on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Finally, Robert W. Baird lowered their target price on shares of HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a research note on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $462.64.

Read Our Latest Stock Analysis on HCA

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Read More

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.